Cargando…
Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients
INTRODUCTION: Sustained remission should be considered the main therapeutic target in psoriatic arthritis (PsA). Very low disease activity (VLDA) and a DAPSA score ≤ 4 are the most commonly used criteria. The aim of the present study was to evaluate the rate of sustained remission in a group of PsA...
Autores principales: | Lubrano, Ennio, Perrotta, Fabio Massimo, Scriffignano, Silvia, Coates, Laura C., Helliwell, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858418/ https://www.ncbi.nlm.nih.gov/pubmed/31428989 http://dx.doi.org/10.1007/s40744-019-00171-w |
Ejemplares similares
-
The “Climb” Towards Minimal Disease Activity in Psoriatic Arthritis
por: Lubrano, Ennio, et al.
Publicado: (2021) -
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
por: Lubrano, Ennio, et al.
Publicado: (2023) -
Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective
por: Lubrano, Ennio, et al.
Publicado: (2022) -
Ultrasonographic Evaluation of Entheseal Fibrocartilage in Patients with Psoriatic Arthritis, Athletes and Healthy Controls: A Comparison Study
por: Perrotta, Fabio Massimo, et al.
Publicado: (2023) -
Clinical Characteristics of Potential “Difficult-to-treat” Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort
por: Perrotta, Fabio Massimo, et al.
Publicado: (2022)